Chinook Therapeutics Inc Cvr (ADRO)
R&D Expenses
$9.23M
Quarterly · Period ending: · USD
ADRO R&D Expenses
Latest reported$9.23Mperiod ending
Latest reported$9.23Mperiod ending
ADRO Quarterly R&D Expenses ($4.73M → $9.23M)
Quarterly R&D Expenses
High-resolution chart · PNG
ADRO r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 9,232,000 | |
| 11,108,000 | |
| 15,828,000 | |
| 15,129,000 | |
| 15,510,000 | |
| 16,876,000 | |
| 19,530,000 | |
| 17,613,000 | |
| 18,675,000 | |
| 19,420,000 | |
| 20,128,000 | |
| 22,918,000 | |
| 24,454,000 | |
| 21,440,000 | |
| 20,572,000 | |
| 20,863,000 | |
| 19,046,000 | |
| 26,882,000 | |
| 20,927,000 | |
| 22,657,000 | |
| 11,813,000 | |
| 13,533,000 | |
| 10,646,000 | |
| 5,858,000 | |
| 5,403,000 | |
| 4,729,000 |